期刊文献+

罗哌卡因/乳酸羟基乙酸共聚物微球的小鼠组织生物相容性研究

Tissue Biocompatibility Study of Ropivacaine/Poly (lactide-co-glycolide) Microspheres in Mice
原文传递
导出
摘要 目的:考察罗哌卡因/乳酸羟基乙酸共聚物微球(RVP/PLGA-MS)在小鼠体内的生物相容性。方法:取昆明小鼠40只,随机均分为A、B2组,分别于小鼠一侧下肢手术切开暴露坐骨神经后注入RVP溶液和植入RVP/PLGA-MS(以RVP计每只小鼠给药量约为0.48~0.5mg)后缝合。观察小鼠手术切口的红肿、渗出情况以及愈合时间;1周后比较2组小鼠体重;2周后处死小鼠,电镜下观察2组小鼠局部组织切片及B组全身主要脏器的病理学改变。结果:2组小鼠手术切口愈合情况及体重比较无统计学差异,2组局部组织切片未见明显的病理学改变;B组全身主要脏器均无病理学改变。结论:RVP/PLGA-MS在小鼠体内具有良好的组织相容性。 OBJECTIVE: To study the biocompatibility of Ropivacaine/poly (lactide-co-glycolide) microspheres (RVP/PLGA- MS) in mice in vivo. METHODS: 40 Kunming mice were randomly divide into group A and B. In group A, the sciatic nerve exposed by surgical incision, and sutured after injecting RVP; in group B, the sciatic nerve exposed by surgical incision, and implanted with RVP/PLGA-MS, then sutured (0.48 to 0.5 mg of RVP). The inflammatory reaction, exudation and healing time of operative incision were observed. One week later, body weight of mice was compared between 2 groups. Mice were sacrificed after 2 weeks. The pathological changes of major organs in group B and local tissue slice of 2 groups were observed under light microscope. RESULTS: There was no statistical difference in incision healing and body weight between 2 groups. No significant pathological changes were found in local tissue slices of 2 groups. There were no pathological changes of major organs in group B. CON- CLUSION: RVP/PLGA-MS in mice has a good biocompatibility in vivo.
出处 《中国药房》 CAS CSCD 北大核心 2011年第45期4255-4257,共3页 China Pharmacy
关键词 罗哌卡因/乳酸羟基乙酸共聚物微球 小鼠 局部组织 脏器 病理学 组织相容性 Ropivacaine/poly (lactide-co-glycolide)microspheres Mice Local tissue Organs Pathology Biocompatibility
  • 相关文献

参考文献8

二级参考文献40

  • 1李平,陈建海,蒋青锋,阎玺庆,许启荣.盐酸丁螺环酮缓释片的制备及其体外释放研究[J].中国药房,2007,18(16):1236-1238. 被引量:6
  • 2Tom Yamaguchi,Mike Yamauchi,Toshitsngu sugimoto,et al.In vivo biocmpatibility studies of medisorb(R)65/35 D,L lactide,glycolid copolymer microspheres.Cont Rel,1993,24:81-93.
  • 3Cui F,Cun D,Tao A,et al.Preparation and characterization of melittin-loaded poly (DL-lactic acid) or poly (DL-lactic-co-glycolic acid)rnicrospheres made by the double emulsion method.J Control Release,2005,107:310-319.
  • 4Shikanov A,Domb AJ,Weiniger CF,et al.Long acting local anesthetic-polymer formulation to prolong the effect of analgesia.J Control Release,2007,117:97-103.
  • 5Kopacz DJ,Bernards CM,Allen HW,et al.A model to evaluate the pharmacokinetic and pharmacodynamic variables of extended-release products using in vivo tissue microdialysis in humans:bupivacaine-loaded microcapsules.Anesth Analg,2003,97:124-131.
  • 6de Araujo DR,Tsuneda SS,Cereda CM,et al.Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-beta-cyclodextrin inclusion complex.Eur J Pharm Sci,2008,33:60-71.
  • 7[1]Anderson JM.Perspectives on the in vivo responses of biodegradable polymers[A].In:Biomedical applications of synthetic biodegradable polymers[M].Boca Raton:CRC Press,FL,1995.223-233.
  • 8[2]Okada H,Toguchi H.Biodegradable microspheres in drug delivery[J].Crit Rev Therap,1995,12∶1-99.
  • 9[3]Li S,Vert M.Biodegradation of aliphatic polyesters[A],In:Scott G,Gilead D eds.Degradable Polymers[M].London:Chapman and Hall.1995.43-87.
  • 10[4]Schakenraad JM,Hardon MJ,Feijen J,et al.Enzymatic activity toward poly(L-Lactic acid)implants[J].J Biomed Mater Res,1990,24∶529-545.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部